Industry News
Aromatase inhibitors 'significantly reduce breast cancer deaths'
7/26/2015
A study finds a class of hormonal drugs - aromatase inhibitors - are more effective than tamoxifen for reducing mortality among women with ER-positive breast cancer.
Aromatase inhibitors 'more effective than tamoxifen' for reducing breast cancer deaths
7/26/2015
A study finds a class of hormonal drugs - aromatase inhibitors - are more effective than tamoxifen for reducing mortality among women with ER-positive breast cancer.
'HIV-style campaign' to cut cancer drug prices
7/25/2015
A large group of America's leading cancer specialists have joined forces in support of action against drug prices, drawing up an action plan to curb costs.
Toxin from salmonid fish has potential to treat cancer
7/24/2015
Pathogenic bacteria develop killer machines that work very specifically and highly efficiently.
A study funded by the Patient-Centered Outcomes Research Institute (PCORI) and conducted by researchers at Moffitt Cancer Center seeks participants to determine the effectiveness of educational...
Bavarian Nordic A/S has announced that the first patient has been enrolled in a new phase 2 clinical study of PROSTVAC, the Company's active prostate cancer immunotherapy candidate.
Chemotherapy for near-death cancer patients 'does not improve quality of life'
7/24/2015
A study assessing the impact of chemotherapy for cancer patients who are near death finds the treatment does not improve their quality of life.
Scientists at the University of York believe they have identified how some tiny regulatory molecules in cells can make prostate cancers resistant to radiotherapy.
UCLA scientists have discovered a groundbreaking experimental therapy that has the ability to suppress the development of ulcerative colitis (UC), a disease which causes inflammation in the...
Can patient navigators reduce no-shows for cancer screening follow-up?
7/24/2015
Researchers at Harvard Medical School and Brigham and Women's Hospital reported a 20% decline in the rate of missed appointments for cervical cancer evaluation following a Pap smear when a patient...